BlackRock Investment Management’s Acorda Therapeutics ACOR Stock Holding History

BlackRock Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.43M	Buy	1,963 +343	+21%	+$815K	0.01%	1670
2016 Q3	$4.06M	Sell	1,620 -10	-0.6%	-$29.8K	0.01%	1627
2016 Q2	$4.99M	Buy	1,630 +212	+15%	+$689K	0.01%	1437
2016 Q1	$4.5M	Buy	1,418 +49	+4%	+$203K	0.01%	1440
2015 Q4	$7.03M	Buy	1,369 +8	+0.6%	+$35K	0.01%	1157
2015 Q3	$4.33M	Sell	1,361 -14	-1%	-$54.3K	0.01%	1467
2015 Q2	$5.5M	Buy	1,375 +217	+19%	+$838K	0.01%	1416
2015 Q1	$4.63M	Sell	1,158 -106	-8%	-$485K	0.01%	1421
2014 Q4	$6.2M	Sell	1,264 -6	-0.5%	-$25.7K	0.01%	1220
2014 Q3	$5.16M	Sell	1,270 -83	-6%	-$311K	0.01%	1322
2014 Q2	$5.47M	Buy	1,353 +229	+20%	+$934K	0.01%	1327
2014 Q1	$5.11M	Buy	1,124 +8	+0.7%	+$32.3K	0.01%	1350
2013 Q4	$3.91M	Sell	1,116 -12	-1%	-$46.8K	0.01%	1530
2013 Q3	$4.63M	Buy	1,128 +54	+5%	+$233K	0.01%	1353
2013 Q2	$4.25M	Buy	+1,074	New	+$4.42M	0.01%	1336

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BlackRock Investment Management's ACOR Position: Q4 2016 in Review

BlackRock Investment Management increased its Acorda Therapeutics (ACOR) stake by 21% in Q4 2016, buying an estimated $815K and bringing the position to 1,963 shares worth $4.43M. The position accounts for 0.01% of the portfolio, ranked #1670.

BlackRock Investment Management first reported a position in ACOR in Q2 2013 and has held it in 15 quarters since. The position peaked at $7.03M in Q4 2015. 175 funds tracked by Wall St. Rank hold ACOR as of Q4 2016.

BlackRock Investment Management held 1,963 shares of Acorda Therapeutics worth $4.43M as of Q4 2016.
BlackRock Investment Management bought 343 Acorda Therapeutics shares in Q4 2016, an estimated $815K.
Acorda Therapeutics made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1670 holding.
BlackRock Investment Management first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Acorda Therapeutics position peaked at $7.03M in Q4 2015.
175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.